RCS - Intnl. Biotechnology - Investor Presentation via Investor Meet Company

International Biotechnology Trust

16/10/2026 10:20

RNS Number : 3166Z
  
Intl. Biotechnology Trust PLC
  
16 October 2026
  
 


INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")
 
Investor Presentation via Investor Meet Company
 
International Biotechnology Trust plc is pleased to announce that Ailsa Craig and Marek Poszepczynski will provide a live presentation on the Company's annual results for the year ended 31 August 2026 via the Investor Meet Company platform on Tuesday 3 November 2026 at 14:00 GMT.
 
The presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard before the meeting or at any time during the live presentation.
 
Investors can sign up to Investor Meet Company for free and add to meet INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:
https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor
 
Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the Investor Meet Company platform will automatically be invited.
 
ENDS
 
Enquiries:
 




Schroder Investment Management Limited
 
Charlotte Banks (Press)
Kirsty Preston
 
Natalia de Sousa/ Michelle Taiwo (Company Secretary)                   


 
 
020 7658 6000
 
 
020 7658 6000
 








 
Kaso Legg Communications (Financial PR)
 
Charles Gorman                       
Henry Taylor
Effie Aye Maung Hider
 












 




This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NRAMZMMGLVRGVZG